Fortis Life Sciences 2023 Highlights
January 1, 2024
Fortis Life Sciences is thrilled to recap a year of significant achievements and milestones in 2023. As a testament to our commitment to innovation and excellence, we are proud to highlight some of our key successes from the past year.
International Point of Care (IPOC): In July Fortis announced the acquisition of IPOC, which develops and manufactures key components used in diagnostics, including lyophilized reagents, membranes, recombinant proteins, and controls. IPOC’s recently expanded 36,000 sq. ft. facility is Fortis’ third GMP and ISO 13485 compliant manufacturing site in North America. Learn more.
Spatial Biology CRO Services Launch: At AACR, Fortis expanded our service offerings by launching spatial biology CRO services. Our CRO arm provides scientists with access to the Lunaphore COMET™ and Akoya PhenoImager™ HT, as well as over 200 of our own antibodies validated on these platforms, to image and analyze tissues in up to 40-plex. Learn more.
RTScript™ Reverse Transcriptase: Fortis introduced the RTScript™ Reverse Transcriptase, which is an MMLV-derived polymerase with deactivated RNase H activity and increased thermal stability. In combination with optimized buffers and reagents, our RTScript™ enzyme synthesizes complementary DNA (cDNA) from an RNA template primed with RNA or DNA oligonucleotides. It is sensitive, specific, and capable of synthesizing long cDNA fragments that are appropriate for downstream analysis by PCR, qPCR, or NGS applications. Learn more.
Ultra Uniform Gold Nanoparticle Standards: Fortis continued to advance the nanotechnology field with the release of Ultra Uniform Gold Nanoparticle Standards. These nanospheres have a nearly perfect spherical shape, smooth surfaces, and impressively narrow size distributions (CV < 5%). Provided at 10⁸ particles/mL, these reference materials can be used for instrument calibration. Learn more.
Fortis Life Sciences looks forward to another year of innovation, partnership, and continued support for the global scientific community.
Stay in the know!
Sign up to receive the latest news and information from Fortis Life Sciences.
By clicking “Acknowledge”, you consent to our website's use of cookies to give you the most relevant experience by remembering your preferences and to analyze our website traffic.
